Abbott Laboratories (ABT) Short Interest Ratio & Short Volume $113.39 -1.06 (-0.93%) (As of 10/31/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Abbott Laboratories Short Interest DataAbbott Laboratories (ABT) has a short interest of 13.98 million shares, representing 0.81% of the float (the number of shares available for trading by the public). This marks a 18.17% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 5.71 million shares to cover all short positions.Current Short Interest13,980,000 sharesPrevious Short Interest11,830,000 sharesChange Vs. Previous Month+18.17%Dollar Volume Sold Short$1.62 billionShort Interest Ratio2.5 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares1,739,897,000 sharesFloat Size1,730,000,000 sharesShort Percent of Float0.81%Today's Trading Volume5,311,835 sharesAverage Trading Volume5,705,911 sharesToday's Volume Vs. Average93% Short Selling Abbott Laboratories? Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartABT Short Interest Over TimeABT Days to Cover Over TimeABT Percentage of Float Shorted Over Time Ad WealthPressThis man believes TSLA will reach $500 a share…Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link Abbott Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202413,980,000 shares $1.62 billion +18.2%0.8%2.5 $116.04 9/30/202411,830,000 shares $1.35 billion -11.5%0.7%2 $114.01 9/15/202413,360,000 shares $1.56 billion +4.8%0.8%2.2 $116.40 8/31/202412,750,000 shares $1.44 billion +0.6%0.7%2.1 $113.27 8/15/202412,680,000 shares $1.41 billion -7.0%0.7%2 $110.95 7/31/202413,630,000 shares $1.44 billion +26.8%0.8%2 $105.96 Get the Latest News and Ratings for ABT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abbott Laboratories and its competitors with MarketBeat's FREE daily newsletter. 7/15/202410,750,000 shares $1.11 billion -17.3%0.6%1.8 $102.99 6/30/202413,000,000 shares $1.35 billion +11.9%0.8%2.3 $103.91 6/15/202411,620,000 shares $1.20 billion -19.9%0.7%2 $103.68 5/31/202414,500,000 shares $1.48 billion -1.8%0.8%2.4 $102.22 5/15/202414,770,000 shares $1.54 billion +2.0%0.9%2.6 $104.56 4/30/202414,480,000 shares $1.53 billion +11.9%0.8%2.6 $105.94 4/15/202412,940,000 shares $1.41 billion -10.6%0.8%2.2 $108.89 3/31/202414,480,000 shares $1.65 billion -7.9%0.8%2.5 $113.66 3/15/202415,720,000 shares $1.80 billion +5.4%0.9%2.9 $114.43 2/29/202414,920,000 shares $1.77 billion +4.4%0.9%3 $118.56 2/15/202414,290,000 shares $1.62 billion +12.5%0.8%2.7 $113.64 1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16 1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92 12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07 12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29 11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30 11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00 10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55 10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87 9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85 9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76 8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90 8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93 7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34 7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93 6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02 6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04 5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00 5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84 4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47 4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96 3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26 3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80 2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72625,000% Gain (Ad)The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull run is over. But if history has taught us anything, it’s that this is only the beginning.>> Dive into the Workshop Here 2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28 1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55 1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51 12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79 12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52 11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58 11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14 10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94 10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91 9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76 9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06 8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65 8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90 7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84 7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82 6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65 6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80 5/31/202213,670,000 shares $1.61 billion +0.7%0.8%2.6 $117.46 5/15/202213,570,000 shares $1.49 billion +0.8%0.8%2.4 $109.88 4/30/202213,460,000 shares $1.53 billion +5.2%0.8%2.5 $113.50 4/15/202212,790,000 shares $1.51 billion +5.7%0.7%2.1 $117.69 3/31/202212,100,000 shares $1.43 billion -9.2%0.7%2 $118.36 3/15/202213,330,000 shares $1.57 billion +28.4%0.8%2.2 $117.48 2/28/202210,380,000 shares $1.25 billion +0.1%0.6%1.6 $120.62 2/15/202210,370,000 shares $1.29 billion +15.4%0.6%1.7 $123.98 1/31/20228,990,000 shares $1.15 billion -0.2%0.5%1.5 $127.46 1/15/20229,010,000 shares $1.15 billion +7.4%0.5%1.6 $128.16 12/31/20218,390,000 shares $1.18 billion -13.3%0.5%1.6 $140.74 12/15/20219,680,000 shares $1.31 billion +11.1%0.6%1.8 $135.56 11/30/20218,710,000 shares $1.10 billion -14.1%0.5%1.7 $125.77 11/15/202110,140,000 shares $1.31 billion -9.7%0.6%2 $129.44 10/29/202111,230,000 shares $1.45 billion +7.0%N/A2.3 $128.89 10/15/202110,500,000 shares $1.23 billion -6.4%0.6%2.3 $117.49 9/30/202111,220,000 shares $1.33 billion +1.5%0.6%2.4 $118.13 9/15/202111,050,000 shares $1.41 billion +8.1%0.6%2.4 $127.49 8/31/202110,220,000 shares $1.29 billion -7.0%0.6%2.1 $126.37 8/13/202110,990,000 shares $1.35 billion -8.0%0.6%1.8 $123.06 7/30/202111,940,000 shares $1.44 billion +2.8%0.7%2 $120.98 7/15/202111,620,000 shares $1.36 billion -14.2%0.7%1.9 $116.66 6/30/202113,550,000 shares $1.57 billion -3.3%0.8%2.2 $115.93 6/15/202114,010,000 shares $1.55 billion -3.8%0.8%2.3 $110.41 5/28/202114,570,000 shares $1.70 billion +2.6%0.8%2.5 $116.65 5/14/202114,200,000 shares $1.67 billion +1.5%N/A2.9 $117.45 4/30/202113,990,000 shares $1.69 billion -4.2%N/A2.8 $121.01 4/15/202114,600,000 shares $1.77 billion +7.0%N/A2.8 $121.50 3/31/202113,640,000 shares $1.63 billion +7.2%N/A2.6 $119.75 3/15/202112,730,000 shares $1.49 billion +30.0%N/A2.5 $116.71 2/26/20219,790,000 shares $1.19 billion -6.7%N/A1.9 $121.58 2/12/202110,490,000 shares $1.33 billion -8.9%N/A2.1 $126.84 1/29/202111,520,000 shares $1.39 billion +29.4%N/A2.3 $120.39625,000% Gain (Ad)The recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull run is over. But if history has taught us anything, it’s that this is only the beginning.>> Dive into the Workshop Here 1/15/20218,900,000 shares $979.36 million -10.5%N/A1.8 $110.04 12/31/20209,940,000 shares $1.08 billion +11.9%N/A2.1 $108.44 12/15/20208,880,000 shares $948.30 million -9.1%N/A1.8 $106.79 11/30/20209,770,000 shares $1.05 billion -17.6%N/A2 $107.62 11/15/202011,850,000 shares $1.33 billion +19.5%N/A2.1 $112.60 10/30/20209,920,000 shares $1.04 billion +5.6%N/A1.8 $105.00 10/15/20209,390,000 shares $1.01 billion -0.5%N/A1.8 $107.75 9/30/20209,440,000 shares $1.03 billion +8.8%N/A1.8 $108.83 9/15/20208,680,000 shares $925.11 million -16.5%N/A1.6 $106.58 8/31/202010,400,000 shares $1.14 billion +3.1%N/A1.9 $109.47 8/14/202010,090,000 shares $1.01 billion -20.6%N/A2 $99.99 7/31/202012,710,000 shares $1.28 billion +25.0%N/A2.2 $100.64 7/15/202010,170,000 shares $983.74 million -6.7%0.6%1.6 $96.73 6/30/202010,900,000 shares $996.59 million -15.0%N/A1.4 $91.43 6/15/202012,820,000 shares $1.15 billion -13.7%N/A1.4 $89.55 5/29/202014,860,000 shares $1.41 billion -18.0%N/A1.4 $94.92 5/15/202018,120,000 shares $1.63 billion -7.4%N/A1.6 $89.89 4/30/202019,570,000 shares $1.80 billion -8.8%1.1%1.9 $92.09 4/15/202021,450,000 shares $1.95 billion +20.7%1.2%2.1 $90.94 3/31/202017,770,000 shares $1.67 billion -22.9%1.0%2 $94.06 3/13/202023,053,500 shares $1.98 billion +21.5%1.3%4.2 $86.04 2/28/202018,970,000 shares $1.19 billion +3.7%1.1%3.4 $62.82 2/14/202018,300,000 shares $1.48 billion +0.8%1.1%3.8 $80.88 1/31/202018,160,000 shares $1.48 billion -12.9%N/A3.9 $81.36 1/15/202020,850,000 shares $1.86 billion +3.4%1.2%4.3 $89.17 12/31/201920,160,000 shares $1.82 billion +4.4%1.2%4.3 $90.40 ABT Short Interest - Frequently Asked Questions What is Abbott Laboratories' current short interest? Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 13,980,000 shares of ABT short. 0.81% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest. What is a good short interest ratio for Abbott Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 2.0. Learn More on Abbott Laboratories's short interest ratio. Which institutional investors are shorting Abbott Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: IMC Chicago LLC, Wealth Enhancement Advisory Services LLC, Claro Advisors LLC, Concourse Financial Group Securities Inc., Oak Hill Wealth Advisors LLC, SG Americas Securities LLC, Point72 DIFC Ltd, Point72 Asset Management L.P., Creative Planning, Susquehanna International Group LLP, Millennium Management LLC, D. E. Shaw & Co. Inc., Squarepoint Ops LLC, Cubist Systematic Strategies LLC, Point72 DIFC Ltd, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Abbott Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Abbott Laboratories' floating shares are currently sold short. Is Abbott Laboratories' short interest increasing or decreasing? Abbott Laboratories saw a increase in short interest in October. As of October 15th, there was short interest totaling 13,980,000 shares, an increase of 18.2% from the previous total of 11,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Abbott Laboratories' float size? Abbott Laboratories currently has issued a total of 1,739,897,000 shares. Some of Abbott Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abbott Laboratories currently has a public float of 1,730,000,000 shares. How does Abbott Laboratories' short interest compare to its competitors? 0.81% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Abbott Laboratories: Intuitive Surgical, Inc. (1.00%), Pfizer Inc. (1.25%), AstraZeneca PLC (0.13%), Novartis AG (0.24%), Sanofi (0.32%), Stryker Co. (1.20%), Merck & Co., Inc. (1.03%), Boston Scientific Co. (0.77%), Vertex Pharmaceuticals Incorporated (1.67%), Medtronic plc (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Abbott Laboratories stock? Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading down $1.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abbott Laboratories? A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further. How often is Abbott Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ISRG Short Interest Data PFE Short Interest Data AZN Short Interest Data NVS Short Interest Data SNY Short Interest Data SYK Short Interest Data MRK Short Interest Data BSX Short Interest Data VRTX Short Interest Data MDT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ABT) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Share Abbott Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
